Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and in Canada
Total 0 results
Nothing found
Sponsors and Collaborators
Familien Hede Nielsens Fond
Markham Stouffville Hospital
Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
UZ Leuven, campus Pellenberg (Belgium)
Hospital Samaritano Paulista
Nestlé Health Science Belgium
Physip S.A
Advanced Life Solutions
Dr. Praveen B.H
Fogarty International Center of the National Institute of Health
Pedro Gamito
The Fred Hollows Foundation, Australia
IN-JET APS
Prof. Jacques SCHRENZEL
JMI Laboratories
Custom Pharmaceuticals Limited
Janssen (China) Research & Development Center
Hazelden Betty Ford Foundation
Universitatea de Medicina si Farmacie Iuliu Hatieganu
Stannah Stairlifts
View Full List
Medical Conditions
Painless Hysteroscopy
Pulmonary Adenocarcinoma
Ewing's Family Tumors
Spine Surgeries
Chlamydophila Infections
Fetus or Neonate Affected by External Version Before Labor
Skull Base Neoplasms
Epidemic Hemorrhagic Fever
Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
Endocarditis Infective
Tay-Sachs Disease Ganglioside
Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
Fracture Dislocation of Cervical Spine
Childhood Langerhans Cell Histiocytosis
Psoriasis, Arthritic
Gullian Barre Syndrome
Multisystem Proteinopathy
Cutaneous Leiomyomata With Uterine Leiomyomata
Closure; Foramen Ovale
Predictors of Atrial Fibrillation Recurrences
View Full List
Drug Interventions
Estradiol+Drospirenone
Adapalene Gel 0.3%
EFV +TVA
Semapimod
Cereport
Neihulizumab
Naltrexone 50 mg/day + Cognitive Behavioral Therapy
PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
Mocetinostat - Recommended Phase 2 Dose (70 mg)
Azelastine hydrochloride (BAYR9258)
Redifferentiation with retinoid acid
Adriamycin
Vehicle
Chemotherapeutic Agent
Palliative care group first-line scheme
Esomeprazole 40mg before
Qingkailing injection 40 ml
NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
Glimepiride
High dose pantoprazole infusion
View Full List
CROs by country
Contract Research Organizations in Albania
Contract Research Organizations in Bahrain
Contract Research Organizations in Greece
Contract Research Organizations in Hungary
Contract Research Organizations in Japan
Contract Research Organizations in Lebanon
Contract Research Organizations in Malaysia
Contract Research Organizations in New Zealand
Contract Research Organizations in Senegal
Contract Research Organizations in South Korea
Contract Research Organizations in Sweden
Contract Research Organizations in Turkmenistan
Contract Research Organizations in Ukraine
CRO list by country
CROs in Gabon
SGS
All CROs in Gabon
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe